Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
Yoshiyuki Suzuki(Toranomon Hospital), Kenji Ikeda(Toranomon Hospital), Fumitaka Suzuki(Toranomon Hospital), Joji Toyota(Sapporo Kosei General Hospital), Yoshiyasu Karino(Sapporo Kosei General Hospital), Kazuaki Chayama(Hiroshima University), Yoshiiku Kawakami(Hiroshima University), Hiroki Ishikawa(Bristol-Myers Squibb (Japan)), Hideaki Watanabe(Bristol-Myers Squibb (Japan)), Wenhua Hu(Bristol-Myers Squibb (United States)), Timothy Eley(Bristol-Myers Squibb (United States)), Fiona McPhee(Bristol-Myers Squibb (United States)), Eric Hughes(Bristol-Myers Squibb (United States)), Hiromitsu Kumada(Toranomon Hospital)
Cited by 236
Abstract
Related Papers
No related papers found
Powered by citation graph analysis